Kevin Maruthananth joined the Upstream Lab of St. Michael’s Hospital as a Research Coordinator II in 2023. He holds an HBSc in Life Sciences (focusing primarily on Health & Disease) from the University of Toronto. His main initiative is to help conduct research to improve public health and reduce health inequities, which is what drew him to join the Upstream Lab team. Kevin has prior experience in clinical research, working as a Clinical Assistant and as a Research Coordinator I. He has worked on various studies that focused on ocular and nasal reactions/diseases, such as allergies, dry-eye disease, and glaucoma to name a few. At this moment, he is working with the Upstream Lab team on the CanTreatCovid study.
While public health measures and vaccines have reduced the spread of SARS-CoV-2, most scientists predict this virus will become endemic and new variants will continue ...
The COVID-19 pandemic has highlighted the importance of rapid and accurate viral testing at the point of care to both guide patient care and support surveillance. AIM-...
Pandemics such as SARS, COVID-19, H1N1 and the mpox outbreak have shown that Canada needs to enhance preparedness for future health emergencies. More efficient method...
Innovative strategies for early detection of acute respiratory infections: co-design of a tailored surveillance system with primary care providers and emergency depart...